Literature DB >> 22472784

Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population.

Lisa M Ambrose-Lanci1, Meera Vaswani, Toni-Kim Clarke, Angela Zeng, Falk W Lohoff, Thomas N Ferraro, Wade H Berrettini.   

Abstract

The rewarding properties of drugs of abuse are mediated by the mu-opioid receptor (MOR). Genetic variations in MOR and MOR interacting proteins (MORIPs) involved in MOR signaling may increase the risk for drug dependence. The MORIP β-arrestin plays an important role in the regulation of MOR trafficking, thereby highlighting it as a candidate gene for addiction phenotypes. In this case-control association study, DNA samples from cocaine-dependent (n=336) and opioid-dependent (n=335) patients and controls (n=656) were genotyped for seven single nucleotide polymorphisms (rs11868227, rs3786047, rs4522461, rs1045280, rs2271167, rs2036657, and rs4790694) across ARRB2, the gene encoding the β-arrestin 2 protein. No significant differences were observed in genotype or allele frequency between drug-dependent and control individuals for any of the single nucleotide polymorphisms analyzed. Haplotype analysis was similarly negative. Further studies are needed to determine whether variations in ARRB2 (or other MORIPs) are relevant to cocaine or opioid dependence in different ethnic populations or whether they confer a risk that is specific to dependence on other drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472784      PMCID: PMC3920286          DOI: 10.1097/YPG.0b013e3283539528

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  37 in total

1.  Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.

Authors:  M R Hoehe; K Köpke; B Wendel; K Rohde; C Flachmeier; K K Kidd; W H Berrettini; G M Church
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

2.  Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs.

Authors:  L M Karkowski; C A Prescott; K S Kendler
Journal:  Am J Med Genet       Date:  2000-10-09

3.  Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations.

Authors:  Ene-Choo Tan; Chay-Hoon Tan; Umavathy Karupathivan; Eric P H Yap
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

4.  A genetic association study of the mu opioid receptor and severe opioid dependence.

Authors:  James J Crowley; David W Oslin; Ashwin A Patkar; Edward Gottheil; Peter A DeMaria; Charles P O'Brien; Wade H Berrettini; Dorothy E Grice
Journal:  Psychiatr Genet       Date:  2003-09       Impact factor: 2.458

5.  Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.

Authors:  G Bart; M Heilig; K S LaForge; L Pollak; S M Leal; J Ott; M J Kreek
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

6.  mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.

Authors:  F Scott Hall; Michelle Goeb; Xiao-Fei Li; Ichiro Sora; George R Uhl
Journal:  Brain Res Mol Brain Res       Date:  2004-02-05

7.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

8.  Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins.

Authors:  K S Kendler; L M Karkowski; M C Neale; C A Prescott
Journal:  Arch Gen Psychiatry       Date:  2000-03

9.  β-Arrestin2 influences the response to methadone in opioid-dependent patients.

Authors:  B Oneda; S Crettol; M Bochud; J Besson; M Croquette-Krokar; R Hämmig; M Monnat; M Preisig; C B Eap
Journal:  Pharmacogenomics J       Date:  2010-06-01       Impact factor: 3.550

10.  Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Tatyana D Sotnikova; Ivan O Medvedev; Robert J Lefkowitz; Linda A Dykstra; Marc G Caron
Journal:  J Neurosci       Date:  2003-11-12       Impact factor: 6.167

View more
  4 in total

Review 1.  Arrestin mutations: Some cause diseases, others promise cure.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Prog Mol Biol Transl Sci       Date:  2018-10-24       Impact factor: 3.622

Review 2.  Pharmacogenetics of Methadone Response.

Authors:  Francina Fonseca; Marta Torrens
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

3.  β-Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use.

Authors:  Klevis K Karavidha; Margit Burmeister; Mark K Greenwald
Journal:  Am J Addict       Date:  2021-03-30

Review 4.  Pharmacogenomics and Morphine.

Authors:  Adaku Ofoegbu; Earl B Ettienne
Journal:  J Clin Pharmacol       Date:  2021-06-16       Impact factor: 3.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.